Article
Identification of cardiovascular risk factors associated with bone marrow cell subsets in patients with STEMI: a biorepository evaluation from the CCTRN TIME and LateTIME clinical trials.
Basic research in cardiology - 1 Jan 2017
Contreras Ariadna, Orozco Aaron F, Resende Micheline, Schutt Robert C, Traverse Jay H, Henry Timothy D, Lai Dejian, Cooke John P, Bolli Roberto, Cohen Michelle L, Moyé Lem, Pepine Carl J, Yang Phillip C, Perin Emerson C, Willerson James T, Taylor Doris A
Abstract excerpt
Autologous bone marrow mononuclear cell (BM-MNC) therapy for patients with ST-segment elevation myocardial infarction (STEMI) has produced inconsistent results, possibly due to BM-MNC product heterogeneity. Patient-specific cardiovascular risk factors (CRFs) may contribute to variations in BM-MNC composition. We sought to identify associations between BM-MNC subset frequencies and specific CRFs in STEMI patients....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.